Testing a new continuous glucose monitor for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 diabetes for at least 6 months, with an A1C between 7% and 10% (checked in the last 6 months).
- You use insulin (pump, injections, or inhaled) for at least 6 months.
- You can attend three 8-hour clinic visits and have blood drawn from a vein.
- You agree to not take vitamin C during the study and to keep the device dry for 12 hours after each application.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how accurate a new continuous glucose monitor (CGM) called CareSens Air 3 is for adults with type 1 diabetes. You would wear the sensor on your skin to track blood sugar levels, and it may help you manage your diabetes more easily.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
This study tests two new continuous glucose monitoring (CGM) systems—devices that track blood sugar levels throughout the day—to make sure they work accurately and safely. You'll wear both sensors for 17 days while visiting the clinic six times so researchers can compare the readings to blood tests.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.